Patents by Inventor Xi Ren

Xi Ren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250064843
    Abstract: Provided is a method and a medicament for treating amyotrophic lateral sclerosis (ALS) in a subject in need thereof, comprising administering to the subject an effective amount of one or more active agents selected from the group consisting of a retinoic acid receptor alpha (RAR?) agonist, a voltage-gated potassium channel (KCNB2) inhibitor, an adrenergic receptor ?2B (ADRA2B) antagonist, a DNA methyltransferase 3 alpha (DNMT3A) antagonist, an insulin like growth factor 1 receptor (IGF1R) inhibitor, a mitogen-activated protein kinase 1 (MAPK1) inhibitor, a nitric oxide synthase 1 (NOS1) inhibitor, a glucocorticoid receptors (NR3C1) antagonist, and a peptidylprolyl Isomerase A (PPIA) antagonist.
    Type: Application
    Filed: December 20, 2022
    Publication date: February 27, 2025
    Inventors: Bai Lu, Xiaoming Guan, Zavoronkovs Aleksandrs, Wing Frank Pun, Xi Long, Hei Man Liu, Ju Wang, Feng Ren
  • Publication number: 20250051399
    Abstract: Provided are a recombinant expression vector for whooping cough antigens, an engineered bacterium and use thereof. The recombinant expression vector for whooping cough antigens comprises a protein expression cassette for pertactin, a gene for resistance screening, and an upstream recombinant nucleic acid fragment and a downstream recombinant nucleic acid fragment of filamentous haemagglutinin gene, wherein the protein expression cassette for pertactin is located between the upstream recombinant nucleic acid fragment and the downstream recombinant nucleic acid fragment of the filamentous haemagglutinin gene, and the upstream recombinant nucleic acid fragment and the downstream recombinant nucleic acid fragment of the filamentous haemagglutinin gene can undergo homologous recombination with the upstream and downstream of the filamentous haemagglutinin gene, respectively.
    Type: Application
    Filed: November 10, 2022
    Publication date: February 13, 2025
    Applicant: GRAND THERAVAC LIFE SCIENCE (NANJING) CO., LTD.
    Inventors: Jun Ge, Jianqiang Li, Ling Li, Dayan Zhang, Xi Wang, Yinghui Shi, Sulin Ren, Tong Zhou
  • Publication number: 20250038184
    Abstract: A composite negative electrode material includes an inner core and a coating layer on the surface of the inner core, the inner core includes a porous carbon and Si particles distributed on the surface and/or in pores of the porous carbon. The composite negative electrode material is provided with micropores and mesopores, a ratio of the pore volume of the micropores to the pore volume of the mesopores is (2-50):(50-98). An oil absorption value of the composite negative electrode material is smaller than an oil absorption value of the composite negative electrode material after removing the Si particles, and based on the oil absorption value of the composite negative electrode material after removing the Si particles being 100%, a difference between the oil absorption value of the composite negative electrode material after removing the Si particles and the oil absorption value of the composite negative electrode material is ?10%.
    Type: Application
    Filed: October 14, 2024
    Publication date: January 30, 2025
    Inventors: Xi CHEN, Chunlei PANG, Yiming KONG, Jianguo REN, Xueqin HE
  • Publication number: 20240368562
    Abstract: A method for vascular regeneration comprises delivering endothelial cells to a lung scaffold, delivering perivascular cells to the lung scaffold, and providing a multiphase culture program to the scaffold. The multiphase culture program comprises a first phase including delivering an angiogenic medium, e.g., having 40-100 ng/ml of pro-angiogenic factors, and a second phase including delivering a stabilization medium, e.g., having 0.5-2% of serum and 1-20 ng/ml of angiogenic factors.
    Type: Application
    Filed: December 18, 2023
    Publication date: November 7, 2024
    Inventors: Xi Ren, Harald C. Ott
  • Publication number: 20240271102
    Abstract: Methods and materials for making and using apical-out ciliated organoids (e.g., apical-out airway organoids) are provided herein.
    Type: Application
    Filed: June 8, 2022
    Publication date: August 15, 2024
    Inventors: Xi Ren, Piyumi Wijesekara, Amir Barati Farimani, Prakarsh Yadav
  • Publication number: 20240174975
    Abstract: Ruggedized particles or live cells are provided. The particles or cells comprise a cross-linked matrix of nucleic acid and/or nucleic acid analog nanostructures forming a shell about the particle or cell. Methods of making and using the ruggedized particles or live cells are provided. The ruggedized particles or cells may be decorated with environmental sensors, for example, which are prepared from nucleic acid and/or nucleic acid analog nanostructures and may include a FRET pair.
    Type: Application
    Filed: September 7, 2023
    Publication date: May 30, 2024
    Inventors: Rebecca Taylor, Weitao Wang, Xi Ren
  • Patent number: 11827749
    Abstract: A method of preparing a colorless transparent copolyamide-imide resin solution and its fabrication as a thin film has been disclosed. The method details formulations derived from a reaction between one or more units of dianhydride and one or more units of diamine monomers with one or more of the monomers containing fluorine atoms in their structural unit. It enables the fabrication of thin films with superior thermal and mechanical properties along with co-efficient of thermal expansion values as low as 2 ppm/° C. and a tensile modulus as high as 9 GPa. The transparent copolyamide-imide film thus prepared has the potential for utilization in flexible displays such as substrates for thin film transistors (TFT), touch sensor panels (TSP) and cover window in organic light emitting diode (OLED) and liquid crystal display (LCD) applications.
    Type: Grant
    Filed: April 7, 2020
    Date of Patent: November 28, 2023
    Assignees: RAYITEK Hi-Tech Film Company, Ltd., Shenzhen, Ohio State Innovation Foundation
    Inventors: Karthikeyan Perumal, Jonathan Robert Parquette, Kuppusamy Kanakarajan, Xi Ren, ZhenZhong Wang
  • Publication number: 20230287030
    Abstract: The present application provides methods of functionalizing an organ or tissue of a mammal by administering a nutrient (e.g., peracetylated N-azido galactosamine Ac4GalNAz) to the mammal or by culturing an organ or tissue in a bioreactor containing such nutrient. The present application also provides methods of selectively functionalizing extracellular matrix (ECM) of an organ or tissue of a mammal by administering a nutrient (e.g., peracetylated N-azido galactosamine Ac4GalNAz) to the mammal. In some aspects, the present application provides a decellularized scaffold of a mammalian organ or tissue comprising an extracellular matrix, wherein the extracellular matrix of the decellularized scaffold is functionalized with a chemical group that is reactive in a bioorthogonal chemical reaction, such as an azide chemical group. The present application also provides biological prosthetic mesh and mammalian organs and tissues for transplantation prepared according to the methods of the application.
    Type: Application
    Filed: March 8, 2023
    Publication date: September 14, 2023
    Inventors: Harald C. Ott, Xi Ren, Jordan P. Bloom, Taufiek Konrad Rajab
  • Publication number: 20230258994
    Abstract: Disclosed is an arbitrarily tailorable electrochromic device and use thereof, wherein the electrochromic device includes in order of a first transparent flexible substrate, a first transparent electron-conductive layer, an electrochromic layer, an electrolyte solution with automatically curable in presence of air and/or moisture to achieve a self-encapsulation function, an ion storage layer, a second transparent electron-conductive layer and a second transparent flexible substrate. The electrochromic device of the present disclosure is arbitrarily tailorable and can be used in various applications.
    Type: Application
    Filed: April 24, 2023
    Publication date: August 17, 2023
    Inventors: Cheng YANG, Xi REN
  • Patent number: 11697710
    Abstract: A polyimide film contains fluorinated substituents and cardo structures. The polyimide film exhibits excellent heat-resistance, transparency and mechanical properties. The polyimide film has a glass-transition temperature (Tg) of at least 360° C., a coefficient of thermal expansion (CTE) of 50 ppm/° C. or lower, a modulus of at least 4.0 Gpa, a b* value of 5 or lower and yellowness index of 8 or less. The polyimide film can be used as a display substrate or an optical film in a liquid crystal display (LCD), an organic light-emitting diode (OLED) and in other fields where the characteristic features are required.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: July 11, 2023
    Assignees: RAYITEK Hi-Tech Film Company, Ltd., Shenzhen, Jiaxing RAYITEK Film Technology Co., Ltd.
    Inventors: YanYan Jiang, ZhenZhong Wang, Xi Ren, Wei Zhang
  • Publication number: 20230145854
    Abstract: A polyimide precursor solution is disclosed, and a colorless transparent polyimide film manufactured from the polyimide precursor solution. The polyimide precursor solution has diamines, a first dianhydride represented by biphenyl dianhydride, a second dianhydride represented by rigid alicyclic dianhydride, a third dianhydride represented by non-alicyclic dianhydrides and organic solvent. The colorless polyimide films have a modulus of 4.5 GPa or higher, a glass-transition temperature (Tg) of 370° C. or higher, and a yellow index of 3.0 or lower. These polyimide films can be used as substrates for thin film transistor (TFT), touch sensor panel (TSP), and cover window applications in flexible display such as organic light-emitting diode (OLED), flexible liquid crystal display (LCD) and other fields.
    Type: Application
    Filed: January 5, 2023
    Publication date: May 11, 2023
    Inventors: YanYan JIANG, Xi REN, ZhenZhong WANG, LiGuo XIAO
  • Patent number: 11634448
    Abstract: The present application provides methods of functionalizing an organ or tissue of a mammal by administering a nutrient (e.g., peracetylated N-azido galactosamine Ac4GalNAz) to the mammal or by culturing an organ or tissue in a bioreactor containing such nutrient. The present application also provides methods of selectively functionalizing extracellular matrix (ECM) of an organ or tissue of a mammal by administering a nutrient (e.g., peracetylated N-azido galactosamine Ac4GalNAz) to the mammal. In some aspects, the present application provides a decellularized scaffold of a mammalian organ or tissue comprising an extracellular matrix, wherein the extracellular matrix of the decellularized scaffold is functionalized with a chemical group that is reactive in a bioorthogonal chemical reaction, such as an azide chemical group. The present application also provides biological prosthetic mesh and mammalian organs and tissues for transplantation prepared according to the methods of the application.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: April 25, 2023
    Assignee: The General Hospital Corporation
    Inventors: Harald C. Ott, Xi Ren, Jordan P. Bloom, Taufiek Konrad Rajab
  • Publication number: 20220354990
    Abstract: A method of immobilizing extracellular vesicles in an extracellular matrix material provides for improved extracellular vesicle retention in vitro and in vivo. Extracellular matrix materials, such as collagen, are functionalized with chemicals that are complimentary to ligands disposed on the surface of the extracellular vesicle. In one example embodiment, collagen is functionalized with dibenzocyclooctyne and the extracellular vesicle is functionalized with an azide tag. The extracellular vesicle is immobilized within the collagen through a click reaction involving the dibenzocyclooctyne and the azide tag.
    Type: Application
    Filed: May 10, 2022
    Publication date: November 10, 2022
    Applicant: Carnegie Mellon University
    Inventors: Xi Ren, Phil G. Campbell, Yunhui Xing, Saigopalakrishna Saileelaprasa Yerneni
  • Publication number: 20220081660
    Abstract: A perfusion bioreactor system has an inner chamber and scaffold with matching porosities to equalize fluid flow through a bioreactor. The scaffold can be fabricated using additive manufacturing or other fabrication techniques to match the geometrical shape of a defect, such as a facial bone anomaly. The inner chamber is fabricated in a similar manner and has an inner cavity matching the shape of the scaffold to create a unified structure when assembled together with the scaffold. By matching the shapes of the scaffold and inner chamber, free space is eliminated within the interior volume of the bioreactor. Stem cells can be flowed through the bioreactor and attached to the scaffold, which are then cultured to grow a tissue graft.
    Type: Application
    Filed: September 17, 2021
    Publication date: March 17, 2022
    Applicant: CARNEGIE MELLON UNIVERSITY
    Inventors: Xi Ren, Barbie Clara Varghese, Ananya Sushanta Kar, Julia Eve Napolitano, Yunhui Xing
  • Publication number: 20210309804
    Abstract: A method of preparing a colorless transparent copolyamide-imide resin solution and its fabrication as a thin film has been disclosed. The method details formulations derived from a reaction between one or more units of dianhydride and one or more units of diamine monomers with one or more of the monomers containing fluorine atoms in their structural unit. It enables the fabrication of thin films with superior thermal and mechanical properties along with co-efficient of thermal expansion values as low as 2 ppm/° C. and a tensile modulus as high as 9 GPa. The transparent copolyamide-imide film thus prepared has the potential for utilization in flexible displays such as substrates for thin film transistors (TFT), touch sensor panels (TSP) and cover window in organic light emitting diode (OLED) and liquid crystal display (LCD) applications.
    Type: Application
    Filed: April 7, 2020
    Publication date: October 7, 2021
    Inventors: Karthikeyan PERUMAL, Jonathan Robert PARQUETTE, Kuppusamy KANAKARAJAN, Xi REN, ZhenZhong WANG
  • Publication number: 20210095076
    Abstract: A polyimide precursor solution is disclosed, and a colorless transparent polyimide film manufactured from the polyimide precursor solution. The polyimide precursor solution has diamines, a first dianhydride represented by biphenyl dianhydride, a second dianhydride represented by rigid alicyclic dianhydride, a third dianhydride represented by non-alicyclic dianhydrides and organic solvent. The colorless polyimide films have a modulus of 4.5 GPa or higher, a glass-transition temperature (Tg) of 370° C. or higher, and a yellow index of 3.0 or lower. These polyimide films can be used as substrates for thin film transistor (TFT), touch sensor panel (TSP), and cover window applications in flexible display such as organic light-emitting diode (OLED), flexible liquid crystal display (LCD) and other fields.
    Type: Application
    Filed: October 15, 2019
    Publication date: April 1, 2021
    Inventors: YanYan JIANG, Xi REN, ZhenZhong WANG, LiGuo XIAO
  • Publication number: 20210040266
    Abstract: A polyimide film contains fluorinated substituents and cardo structures. The polyimide film exhibits excellent heat-resistance, transparency and mechanical properties. The polyimide film has a glass-transition temperature (Tg) of at least 360° C., a coefficient of thermal expansion (CTE) of 50 ppm/° C. or lower, a modulus of at least 4.0 Gpa, a b* value of 5 or lower and yellowness index of 8 or less. The polyimide film can be used as a display substrate or an optical film in a liquid crystal display (LCD), an organic light-emitting diode (OLED) and in other fields where the characteristic features are required.
    Type: Application
    Filed: August 7, 2019
    Publication date: February 11, 2021
    Inventors: YanYan JIANG, ZhenZhong WANG, Xi REN, Wei ZHANG
  • Publication number: 20200354685
    Abstract: A method for vascular regeneration comprises delivering endothelial cells to a lung scaffold, delivering perivascular cells to the lung scaffold, and providing a multiphase culture program to the scaffold. The multiphase culture program comprises a first phase including delivering an angiogenic medium, e.g., having 40-100 ng/ml of pro-angiogenic factors, and a second phase including delivering a stabilization medium, e.g., having 0.5-2% of serum and 1-20 ng/ml of angiogenic factors.
    Type: Application
    Filed: July 23, 2020
    Publication date: November 12, 2020
    Inventors: Xi Ren, Harald C. Ott
  • Patent number: 10731135
    Abstract: A method for vascular regeneration comprises delivering endothelial cells to a lung scaffold, delivering perivascular cells to the lung scaffold, and providing a multiphase culture program to the scaffold. The multiphase culture program comprises a first phase including delivering an angiogenic medium, e.g., having 40-100 ng/ml of pro-angiogenic factors, and a second phase including delivering a stabilization medium, e.g., having 0.5-2% of serum and 1-20 ng/ml of angiogenic factors.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: August 4, 2020
    Assignee: The General Hospital Corporation
    Inventors: Xi Ren, Harald C. Ott
  • Publication number: 20200031997
    Abstract: A transparent polyimide film with low birefringence, high glass transition temperature (Tg) consists of polyimide essentially comprising non-linear structure. This polyimide is prepared by a mixture of dianhydrides and diamines, comprising at least 10 mol % of asymmetric dianhydride and 50 mol % or less of meta-substituted diamine. This transparent polyimide film has a transmittance of 85% or more at 550 nm, a birefringence value of 0.005 or less and a Tg of 300° C. or more. The present invention relates to the low birefringence required electro-optic field, including the substrate and cover window for flexible OLED and LCD displays.
    Type: Application
    Filed: November 16, 2018
    Publication date: January 30, 2020
    Inventors: Xi REN, Zhenzhong WANG, Yong HU, Wei ZHANG